• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform

August 17, 2022 By Sean Whooley

Nuvo logoNuvo Group announced today that it completed the first phase of a collaboration agreement with Sheba Medical Center’s “Sheba BEYOND.”

The first phase of the partnership included a pilot program centered around gestational diabetes management. The program shifted necessary non-stress tests (NSTs) to home-based, remote monitoring using Nuvo’s INVU rather than conducting traditional monitoring in a medical facility.

Participating physicians prescribed INVU to expectant mothers who wore the sensor band from home during virtual visits. During the virtual visits, anchored by the hospital’s Sheba BEYOND virtual hospital platform, a live reading allowed the expectant mother to access simplified data and insights through the INVU app while the provider garnered more detailed fetal and maternal surveillance that OB/GYNs are accustomed to receiving during in-office visits, according to a news release.

According to the companies, the pilot program also featured the use of other telemedicine offerings alongside INVU, including a remote ultrasound device, glucose monitoring, and home urinalysis kit. They said the program aimed to help patients and providers save time and ultimately improve the overall care experience.

“Our long-term goal is to provide pregnant women with the best possible maternal-fetal surveillance wherever they are – in our clinics, at the comfort of their home or during their workday,” said Dr. Avi Tsur, high-risk pregnancy expert and director of Sheba’s Women’s Health Innovation Center and Sheba BEYOND’s Obstetrics & Gynecology Beyond tele-health platform. “The INVU fetal monitoring solution has the potential to be a catalyst of transformative care in an area of medicine that has been lagging in innovation and new approaches for decades. I hope this pilot is only the beginning.”

The next phase of the partnership will look to integrate the INVU platform into the hospital’s standard of care protocols. The companies also plan to utilize data collected from the pilot program to develop new AI tools with the goals of advancing pregnancy care management, improving outcomes, and lowering costs.

“It is an honor to collaborate with a leading medical center like Sheba to bring Nuvo’s INVU technology to expectant mothers in Israel,” said Kelly Londy, CEO of Nuvo Group. “The INVU platform is particularly beneficial for high-risk pregnancies that would otherwise require frequent in-office visits, which we know can become burdensome on all sides. We look forward to the next phase of our partnership as we continue to work with Sheba to help deliver safe and reliable remote care to even more patients.”

Filed Under: Diabetes, Featured, Hospital Care, Technology, Women's Health Tagged With: Nuvo, Sheba Medical Center

IN CASE YOU MISSED IT

  • Enable Injections, Sanofi obtain approval for on-body myeloma therapy in Japan
  • Abbott sets Libre Duo glucose-ketone sensor US launch for December
  • Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
  • MiniMed completes split from Medtronic
  • Insulet’s Omnipod Discover data platform begins full US rollout

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS